Condition
Post-concussive Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02690584Not ApplicableCompleted
Metacognitive Therapy for Post-concussive Symptoms After Mild Traumatic Brain Injury
NCT01762475Phase 2Completed
Sildenafil for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury.
NCT01101724Not ApplicableCompleted
Effect of Early Rest on Recovery From Pediatric Concussion
NCT01220713Phase 2Completed
Hyperbaric Oxygen Therapy (HBO2T) for Post-Concussive Symptoms (PSC) After Mild Traumatic Brain Injury (mTBI)
Showing all 4 trials